UV Germi SA (EPA:ALUVI)
France · Delayed Price · Currency is EUR 2.320
0.00 (0.00%)
Nov 10, 2026, 1:59 PM CET
UV Germi Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Other Revenue | -0 | -0 | - | - | - | 0 |
| 7.16 | 6.81 | 8.51 | 8.04 | 7.16 | 6.5 | |
Revenue Growth | -8.08% | -20.05% | 5.93% | 12.18% | 10.20% | -5.27% |
Cost of Revenue | 3.94 | 3.94 | 4.86 | 4.7 | 4.25 | 3.84 |
Gross Profit | 3.22 | 2.87 | 3.65 | 3.34 | 2.91 | 2.66 |
Selling, General & Admin | 2.7 | 2.7 | 2.9 | 2.75 | 2.57 | 2.51 |
Other Operating Expenses | 0.23 | -0.29 | -0.11 | -0.04 | 0.01 | 0.02 |
Operating Expenses | 3.32 | 2.81 | 3.15 | 3.05 | 2.89 | 2.84 |
Operating Income | -0.1 | 0.06 | 0.5 | 0.29 | 0.02 | -0.18 |
Interest Expense | - | -0.01 | -0 | -0 | -0 | -0 |
Interest & Investment Income | 0.06 | 0.06 | 0.09 | 0.03 | 0.01 | 0.01 |
Currency Exchange Gain (Loss) | -0 | -0 | -0 | -0 | - | - |
Other Non Operating Income (Expenses) | -0 | -0 | 0 | -0 | - | 0 |
EBT Excluding Unusual Items | -0.04 | 0.11 | 0.59 | 0.31 | 0.02 | -0.17 |
Gain (Loss) on Sale of Investments | -0.1 | -0.1 | -0.04 | -0.04 | -0.08 | -0.86 |
Gain (Loss) on Sale of Assets | 0.02 | 0.02 | - | 0.03 | -0.91 | - |
Asset Writedown | - | - | - | -0.15 | - | - |
Other Unusual Items | -0 | -0 | 0.02 | -0.02 | 0.86 | -0.01 |
Pretax Income | -0.13 | 0.02 | 0.57 | 0.13 | -0.11 | -1.04 |
Income Tax Expense | -0.07 | -0.08 | -0.14 | -0.16 | -0.17 | -0.17 |
Net Income | -0.06 | 0.1 | 0.71 | 0.29 | 0.07 | -0.87 |
Net Income to Common | -0.06 | 0.1 | 0.71 | 0.29 | 0.07 | -0.87 |
Net Income Growth | - | -85.73% | 144.73% | 339.55% | - | - |
Shares Outstanding (Basic) | - | 3 | 3 | 3 | 3 | 3 |
Shares Outstanding (Diluted) | - | 3 | 3 | 3 | 3 | 3 |
Shares Change | - | 0.83% | - | 2.37% | 21.22% | -0.27% |
EPS (Basic) | - | 0.03 | 0.22 | 0.09 | 0.02 | -0.34 |
EPS (Diluted) | - | 0.03 | 0.22 | 0.09 | 0.02 | -0.34 |
EPS Growth | - | -85.85% | 144.73% | 329.38% | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 44.95% | 42.12% | 42.87% | 41.56% | 40.63% | 40.96% |
Operating Margin | -1.44% | 0.84% | 5.89% | 3.59% | 0.24% | -2.70% |
Profit Margin | -0.82% | 1.49% | 8.34% | 3.61% | 0.92% | -13.38% |
EBITDA | 0.29 | 0.46 | 0.86 | 0.63 | 0.33 | 0.14 |
EBITDA Margin | 4.08% | 6.79% | 10.08% | 7.82% | 4.61% | 2.11% |
D&A For EBITDA | 0.39 | 0.4 | 0.36 | 0.34 | 0.31 | 0.31 |
EBIT | -0.1 | 0.06 | 0.5 | 0.29 | 0.02 | -0.18 |
EBIT Margin | -1.44% | 0.84% | 5.89% | 3.59% | 0.24% | -2.70% |
Revenue as Reported | 7.32 | 7.32 | 8.81 | 8.34 | 7.63 | 7.14 |